org/ 0000- 0001- 8624- 7108 reFerenCes 1 Colella TA, Bullock TN, Russell LB, et al. Self- tolerance to the murine homologue of a tyrosinase- derived melanoma antigen: implications for tumor immunotherapy. J Exp Med 2000;191:1221–31. 2 Carreno BM, Magrini V, Becker- Hapak M, et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen- specific T cells. Science 2015;348:803–8.